Subscribe to our Newsletters !!
Few developments in science and technology have be
In modern pharmaceutical and laboratory settings,
A new COVID-19 variant, BA.3.2, informally called
Alembic Pharmaceuticals Limited (Alembic) today an
2026 marks a new chapter for the pharmaceutical an
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to a fresh and forward-lo
Pfizer Inc and BioNTech SE have consented to provide Japan with 120 million doses of their mRNA-based vaccine candidate against the novel coronavirus in the first half of 2021, the companies said on Friday.
The companies said, assuming achievement of the vaccine in clinical studies, they are on track to look for regulatory review to get the vaccine as early as October.
The companies didn’t disclose the financial details of their arrangement.
